Kenneth E Truitt

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 4

Top Topics

Top Venues

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Kenneth E Truitt, Robert P Anderson
Editorial: a non-dietary treatment for coeliac disease-two steps forward, one step back? Authors' reply. Alimentary pharmacology & therapeutics 50 (8) (2020)
A James M Daveson, Jason A Tye-Din, Gautam Goel, Kaela E Goldstein, Holly L Hand, Kristin M Neff, Leslie J Williams, Kenneth E Truitt, Robert P Anderson, null null
Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease. Alimentary pharmacology & therapeutics 51 (2) (2019)
Kenneth E Truitt, A James M Daveson, Hooi C Ee, Gautam Goel, James MacDougall, Kristin Neff, Robert P Anderson
Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease. Alimentary pharmacology & therapeutics 50 (5) (2019)
Jason A Tye-Din, A James M Daveson, Hooi C Ee, Gautam Goel, James MacDougall, Sarah Acaster, Kaela E Goldstein, John L Dzuris, Kristin M Neff, Kenneth E Truitt, Robert P Anderson
Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease. Alimentary pharmacology & therapeutics 50 (8) (2019)